Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07482722

Virtual Reality-Based Transitional Care for ICU Survivors

This study aims to evaluate the effectiveness of a virtual reality (VR)-based transitional care program for adult survivors of intensive care unit (ICU) care. ICU survivors frequently experience relocation stress, anxiety, pain, and physiological instability after transfer from the ICU to general wards, which may increase the risk of unplanned ICU readmission.

Participants will be randomly assigned to receive either standard transitional care or additional VR-based intervention sessions during their ICU stay. The VR intervention is designed to provide psychological support, environmental orientation, and stress reduction.

Primary outcomes include short-term physiological indicators within 48 hours after ICU transfer. Secondary outcomes include pain, relocation stress, and unplanned ICU readmission within 7 days.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MacKay Memorial Hospital, Taipei, Taipei City, Taiwan

Loading trial locations.

About this study

This is a single-center, randomized controlled trial designed to investigate the effects of a virtual reality (VR)-based transitional care intervention on physiological stability and psychological adaptation among adult ICU survivors.

Critically ill patients often experience relocation stress syndrome following transfer from the ICU to general wards. This transition period is associated with increased anxiety, pain perception, autonomic imbalance, and a higher risk of unplanned ICU readmission.

Eligible participants will be randomized using block randomization into the intervention or control group. The intervention group will receive three VR sessions during their ICU stay in addition to standard transitional care. The control group will receive standard care alone.

The primary outcome is short-term physiological stability measured within 48 hours after ICU transfer. Secondary outcomes include heart rate variability parameters, pain intensity, relocation stress, and unplanned ICU readmission within 7 days.

This study seeks to determine whether VR-assisted transitional care can enhance recovery, reduce stress-related responses, and improve patient outcomes following ICU discharge.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 20 years or older
  • Adult patients admitted to the intensive care unit (ICU)
  • Planned transfer from ICU to the general ward
  • Able to communicate and provide informed consent or have a legal representative provide consent

Exclusion criteria

  • Severe cognitive impairment or delirium preventing participation
  • Severe visual or hearing impairment interfering with VR use
  • Hemodynamic instability requiring immediate life-saving intervention
  • Isolation precautions prohibiting device use
  • Participation in another interventional study that may affect outcomes

Treatment and study plan

Virtual Reality-Based Transitional Care

Behavioral

Participants assigned to this arm will receive three structured virtual reality (VR) sessions during their ICU stay in addition to standard transitional care. Each VR session is designed to provide environmental orientation, psychological support, and stress reduction through immersive audiovisual content. The intervention aims to improve short-term physiological stability and reduce relocation stress following ICU transfer.

Primary outcomes

  1. Heart Rate Variability - RMSSD

    Time frame: Within 48 hours after transfer from the ICU to the general ward

    Heart rate variability measured using the Root Mean Square of Successive Differences (RMSSD) derived from electrocardiographic recordings.

  2. Heart Rate Variability - High Frequency Power

    Time frame: Within 48 hours after transfer from the ICU to the general ward

    Heart rate variability measured using high-frequency (HF) power derived from electrocardiographic recordings.

Secondary outcomes

  1. Pain Intensity

    Time frame: Within 48 hours after ICU transfer

    Pain intensity will be assessed using the Defense and Veterans Pain Rating Scale (DVPRS), a numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.

  2. Unplanned ICU Readmission

    Time frame: Within 7 days after ICU transfer

    Occurrence of unplanned readmission to the ICU within 7 days after transfer to the general ward.

  3. Relocation Stress

    Time frame: Within 48 hours after ICU transfer

    Relocation stress will be assessed using the Relocation Stress Syndrome Scale - Short Form (RSSS-SF). The scale consists of items rated on a Likert scale, with higher scores indicating greater relocation stress.

Study contacts

Contact information is provided by the study sponsor or research team.

Yu-Ling Yang, RN, NP

CONTACT

[email protected]

+886-2-25433535

Yu-Ling Yang, RN, NP

CONTACT

[email protected]

+886-2-25433535

Sponsors and collaborators

Lead sponsor

Mackay Memorial Hospital

Other

Registry information

Official study title

Impact of a Virtual Reality-Based Transitional Care Program on Heart Rate Variability, Pain, Relocation Stress, and Unplanned ICU Readmission Among Adult ICU Survivors: A Randomized Controlled Trial

Acronym: VRICU

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 19, 2026
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.